232 related articles for article (PubMed ID: 20694964)
1. SSRI treatment during pregnancy: are we asking the right questions?
Wisner KL
Depress Anxiety; 2010 Aug; 27(8):695-8. PubMed ID: 20694964
[No Abstract] [Full Text] [Related]
2. Publishing statistically significant results with questionable clinical importance: focus on antidepressant use in pregnancy.
Einarson A
J Clin Psychiatry; 2012 Nov; 73(11):1443-6. PubMed ID: 23218161
[No Abstract] [Full Text] [Related]
3. Do Maternal Pharmacogenetics Impact the Neonatal Abstinence Syndrome Following In Utero Exposure to Antidepressant Medications?
Shea AK; Wang DY; Snelgrove JW; Dalfen A; Hewko S; Murphy KE
J Obstet Gynaecol Can; 2021 Jun; 43(6):726-732. PubMed ID: 33303407
[TBL] [Abstract][Full Text] [Related]
4. Depression in pregnancy: risks to mother...and to her baby: neonatal abstinence syndrome...and serious respiratory problems.
Child Health Alert; 2006 Mar; 24():3-4. PubMed ID: 16562344
[No Abstract] [Full Text] [Related]
5. The use of serotonin reuptake inhibitors in pregnancy.
Malek-Ahmadi P
Can J Psychiatry; 2000 Dec; 45(10):939-40. PubMed ID: 11190370
[No Abstract] [Full Text] [Related]
6. [Selective serotonin reuptake inhibitors and pregnancy].
Hassanzadeh T; Pedersen LH; Videbech P
Ugeskr Laeger; 2014 Feb; 176(3):236-9. PubMed ID: 24629751
[TBL] [Abstract][Full Text] [Related]
7. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
Yang A; Ciolino JD; Pinheiro E; Rasmussen-Torvik LJ; Sit DKY; Wisner KL
J Clin Psychiatry; 2017 May; 78(5):605-611. PubMed ID: 28570796
[TBL] [Abstract][Full Text] [Related]
8. [SSRIs and pregnancy: a review of the literature].
Soufia M; Aoun J; Gorsane MA; Krebs MO
Encephale; 2010 Dec; 36(6):513-6. PubMed ID: 21130237
[TBL] [Abstract][Full Text] [Related]
9. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
Casper RC; Gilles AA; Fleisher BE; Baran J; Enns G; Lazzeroni LC
Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn.
Reefhuis J; Rasmussen SA; Friedman JM
N Engl J Med; 2006 May; 354(20):2188-90; author reply 2188-90. PubMed ID: 16707761
[No Abstract] [Full Text] [Related]
11. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
Colvin L; Slack-Smith L; Stanley FJ; Bower C
CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors in pregnancy.
Bellissima V; Ververs TF; Visser GH; Gazzolo D
Curr Med Chem; 2012; 19(27):4554-61. PubMed ID: 22876893
[TBL] [Abstract][Full Text] [Related]
13. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H
PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant use and preterm birth.
Urato AC
Am J Psychiatry; 2009 Oct; 166(10):1189; author reply 1189-90. PubMed ID: 19797450
[No Abstract] [Full Text] [Related]
16. In utero SSRI exposure and risk of clubfoot.
Henriksen DP; Pottegård A; Jimenez-Solem E; Damkier P
Epidemiology; 2015 May; 26(3):e34-5. PubMed ID: 25835138
[No Abstract] [Full Text] [Related]
17. Concerns regarding antidepressant drug use during pregnancy.
Urato AC
J Psychiatry Neurosci; 2006 Nov; 31(6):411; author reply 411-2. PubMed ID: 17136220
[No Abstract] [Full Text] [Related]
18. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
Grzeskowiak LE; Gilbert AL; Sørensen TI; Olsen J; Sørensen HT; Pedersen LH; Morrison JL
Ann Epidemiol; 2013 Nov; 23(11):681-7. PubMed ID: 24113367
[TBL] [Abstract][Full Text] [Related]
19. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
20. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
